blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2295557

EP2295557 - Exoamylase variants [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2018
Database last updated on 06.11.2024
FormerThe patent has been granted
Status updated on  04.08.2017
FormerGrant of patent is intended
Status updated on  30.03.2017
FormerExamination is in progress
Status updated on  25.11.2016
Most recent event   Tooltip26.06.2020Lapse of the patent in a contracting state
New state(s): CY		published on 29.07.2020  [2020/31]
Applicant(s)For all designated states
DuPont Nutrition Biosciences ApS
Langebrogade 1
1411 Copenhagen K / DK
For all designated states
Genencor International, Inc.
925 Page Mill Road
Palo Alto, CA 94304 / US
[2016/20]
Former [2012/33]For all designated states
DuPont Nutrition Biosciences ApS
Langebrogade 1
Postboks 17
1001 Copenhagen K. / DK
For all designated states
Genencor International, Inc.
925 Page Mill Road
Palo Alto, CA 94304 / US
Former [2012/27]For all designated states
Dupont Nutrition Biosciences ApS
Langebrogade 1
P.O. Box 17
1001 Copenhagen K / DK
For all designated states
Genencor International, Inc.
925 Page Mill Road
Palo Alto, CA 94304 / US
Former [2011/11]For all designated states
Danisco A/S
Langebrogade 1 PO Box 17
1001 Copenhagen K / DK
For all designated states
Genencor International, Inc.
925 Page Mill Road
Palo Alto, CA 94304 / US
Inventor(s)01 / Berg, Casper Tune
Baneskellet 50
DK-2950, Vedbæk / DK
02 / Thoudahl, Charlotte Refdahl
Holmeås 51
DK-2670, Greve / DK
03 / Derkx, Patrick Maria Franciscus
Søgårdsvej 1
DK-3080, Tikøb / DK
04 / Fioresi, Carol
408 Northumberland Avenue
Redwood City, CA 94061-3480 / US
05 / Gerritse, Gijsbert
Kruisbespad 2
2995, TC Heerjansdam / NL
06 / Kellett-Smith, Anja Hemmingen
Langelinieparken 3C, st. leji 2
DK-8000, Aarhus C / DK
07 / Kragh, Karsten Mathias
Råhøjtoften 9
DK-8260, Viby J / DK
08 / Liu, Wei
20371 Royal Avenue
Hayward, CA 94541 / US
09 / Shaw, Andrew
25 Sierra Street 310E
San Francisco, CA 94107 / US
10 / Sørensen, Bo Spange
Fenrisvej 15
DK-8660, Skanderborg / DK
 [2017/36]
Former [2011/11]01 / Berg, Casper Tune
Baneskellet 50
DK-2950, Vedbæk / DK
02 / Thoudahl, Charlotte Refdahl
Holmeås 51
DK-2670, Greve / DK
03 / Derkx, Patrick Maria Franciscus
Søgårdsvej 1
DK-3080, Tikøb / DK
04 / Fioresi, Carol
408 Northumberland Avenue
Redwood City, CA 94061-3480 / US
05 / Gerritse, Gijsbert
Kruisbespad 2
2995, TC Heerjansdam / NL
06 / Kellett-Smith, Anja Hemmingen
Langelinieparken 3C, st. leji 2
DK-8000, Aarhus C / DK
07 / Kragh, Karsten Mathias
Råhøjtoften 9
DK-8260, Viby J / DK
08 / Liu, Wei
20371 Royal Avenue
Hayward, CA 94541 / US
09 / Shaw, Andrew
25 Sierra Street 310E
San Francisco, CA 94107 / US
10 / Sørensen, Bo Spange
Fenrisvej 15
DK-8660, Skanderborg / DK
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2017/36]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Former [2011/11]Harding, Charles Thomas
D Young & Co LLP 120 Holborn London
EC1N 2DY / GB
Application number, filing date10178816.407.07.2005
[2011/11]
Priority number, dateUS2004088650507.07.2004         Original published format: US 886505
US2004088652707.07.2004         Original published format: US 886527
US2004088650407.07.2004         Original published format: US 886504
US20040608919P07.07.2004         Original published format: US 608919 P
US2004094761222.09.2004         Original published format: US 947612
US20040612407P22.09.2004         Original published format: US 612407 P
[2011/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2295557
Date:16.03.2011
Language:EN
[2011/11]
Type: A3 Search report 
No.:EP2295557
Date:22.06.2011
[2011/25]
Type: B1 Patent specification 
No.:EP2295557
Date:06.09.2017
Language:EN
[2017/36]
Search report(s)(Supplementary) European search report - dispatched on:EP24.05.2011
ClassificationIPC:C12N9/28, C12P19/14
[2017/13]
CPC:
C12Y302/0106 (EP,CN,US); C12N9/00 (KR); C12N9/2417 (EP,CN,US);
A23K20/189 (EP,CN,US); A21D8/042 (EP,CN,US); A23L29/35 (EP,CN,US);
A23L7/107 (EP,CN,US); A23V2002/00 (EP,CN,US) (-)
C-Set:
A23V2002/00, A23V2300/21 (CN,EP,US)
Former IPC [2011/11]C12N9/28, C12P19/14, A21D8/04, A23L1/09, A23K1/165
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/36]
Former [2011/11]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Exoamylasevarianten[2011/11]
English:Exoamylase variants[2011/11]
French:Variants d'exoamylase[2011/11]
Examination procedure29.11.2011Amendment by applicant (claims and/or description)
09.12.2011Examination requested  [2012/03]
21.01.2013Despatch of a communication from the examining division (Time limit: M06)
10.06.2013Reply to a communication from the examining division
10.12.2014Despatch of a communication from the examining division (Time limit: M04)
01.04.2015Reply to a communication from the examining division
23.02.2016Despatch of a communication from the examining division (Time limit: M04)
07.06.2016Reply to a communication from the examining division
28.06.2016Despatch of a communication from the examining division (Time limit: M04)
13.09.2016Reply to a communication from the examining division
28.09.2016Despatch of a communication from the examining division (Time limit: M02)
25.11.2016Reply to a communication from the examining division
31.03.2017Communication of intention to grant the patent
04.07.2017Receipt of the translation of the claim(s)
31.07.2017Fee for grant paid
31.07.2017Fee for publishing/printing paid
Parent application(s)   TooltipEP05758989.7  / EP1769069
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050758989) is  21.11.2007
Opposition(s)07.06.2018No opposition filed within time limit [2018/33]
Fees paidRenewal fee
06.12.2010Renewal fee patent year 03
06.12.2010Renewal fee patent year 04
06.12.2010Renewal fee patent year 05
06.12.2010Renewal fee patent year 06
25.07.2011Renewal fee patent year 07
25.07.2012Renewal fee patent year 08
29.07.2013Renewal fee patent year 09
14.07.2014Renewal fee patent year 10
10.07.2015Renewal fee patent year 11
11.07.2016Renewal fee patent year 12
12.07.2017Renewal fee patent year 13
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.07.2005
AT06.09.2017
CY06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
TR06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
[2020/31]
Former [2020/27]HU07.07.2005
AT06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
PT06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
TR06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
Former [2020/16]AT06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
TR06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
Former [2019/15]AT06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
MC06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/39]AT06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SI06.09.2017
SK06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/23]AT06.09.2017
CZ06.09.2017
EE06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
PL06.09.2017
RO06.09.2017
SE06.09.2017
SK06.09.2017
BG06.12.2017
GR07.12.2017
IS06.01.2018
Former [2018/21]CZ06.09.2017
FI06.09.2017
LT06.09.2017
LV06.09.2017
SE06.09.2017
BG06.12.2017
GR07.12.2017
Former [2018/12]FI06.09.2017
LT06.09.2017
LV06.09.2017
SE06.09.2017
BG06.12.2017
GR07.12.2017
Former [2018/09]FI06.09.2017
LT06.09.2017
SE06.09.2017
Former [2018/08]FI06.09.2017
LT06.09.2017
Former [2018/07]LT06.09.2017
Documents cited:Search[A]WO0166712  (NOVOZYMES AS [DK], et al) [A] 1,3-57 * abstract * * page 1, lines 4-12 * * page 3, lines 1-11 * * page 5, lines 1-20 * * page 15, line 18 - page 23, line 3 * * page 24, line 37 * * claims 40-49 *;
 [A]WO0231124  (NOVOZYMES AS [DK], et al) [A] 1,3-57 * abstract * * page 1, lines 1-23 * * page 4, line 31 - page 6, line 17 * * page 8, line 35 * * page 9, line 22 - page 10, line 25 * * page 15, lines 14-27 * * page 18, line 20 *;
 [A]WO02068589  (DIVERSA CORP [US]) [A] 1,3-57 * abstract * * page 11, line 12 - page 12, line 6 * * page 20, line 22 - line 31 * * page 21, line 22 - page 22 * * page 55, line 19 - page 68 * * examples 1-10 *;
 [AP]WO2004111217  (DANISCO [DK], et al) [AP] 1,3-57 * abstract * * page 1 - page 7 * * page 10, line 245 - page 69 * * examples 1-10 *;
 [AP]WO2005003339  (DANISCO [DK], et al) [AP] 1,3-57 * abstract * * page 1 - page 3 * * page 9, line 249 - page 55 * * examples 1-14 * * SEQ ID No.2 and 36 *;
 [AP]WO2005007867  (GENENCOR INT [US], et al) [AP] 1,3-57 * abstract * * page 1, lines 21-24 * * page 2, line 20 - page 16, line 3 * * page 19, line 16 - page 20, line 22 * * page 26, line 3 - page 31, line 24 * * page 41, line 20 - page 58, line 10 * * examples 7-12 *;
 [AP]US2005137111  (KRAGH KARSTEN M [DK], et al) [AP] 1,3-57 * abstract * * paragraphs [0002] - [0199] - [0225] , [0258] - [0345] - [0358] , [0364] , [0389] , [0390] , [0408] - [0454] ** examples 7-12 *;
 [X]  - "RecName: Full=Glucan 1,4-alpha-maltotetraohydrolase; Short=G4-amylase; EC=3.2.1.60; AltName: Full=Exo-maltotetraohydrolase; AltName: Full=Maltotetraose-forming amylase; AltName: Full=Maltotetraose-forming exo-amylase; Flags: Precursor;", UniProt, (19910801), Database accession no. P22963, URL: EBI, XP002617424 [X] 1,7,8,12,13,15,16,21 * compound . *
by applicant   - BRADFORD, "A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding", ANAL. BIOCHEM., (1976), vol. 72, pages 248 - 254
    - J. SAMBROOK; E. F. FRITSCH; T. MANIATIS, Molecular Cloning: A Laboratory Manual, Second Edition,, COLD SPRING HARBOR LABORATORY PRESS, (1989), vol. 1-3
    - ED HARLOW, Antibodies : A Laboratory Manual, COLD SPRING HARBOR LABORATORY PRESS, (1988), page 1855
    - JOHN D. POUND, Immunochemical Protocols, HUMANA PRESS, (1998), vol. 80
    - DEVEREUX ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, page 387
    - ATSCHUL ET AL., J. MOL. BIOL., (1990), pages 403 - 410
    - BERNFELD, METHODS ENZYMOL., (1954), vol. 1, pages 149 - 158
    - HENRISSAT B; BAIROCH A, BIOCHEM. J., (1996), vol. 316, pages 695 - 696
    - CHRISTOPHERSEN, C. ET AL., STARCH, (1997), vol. 50, no. 1, pages 39 - 45
    - CARUTHERS MH, NUC ACIDS RES SYMP SER, (1980), pages 215 - 23
    - HORN T ET AL., NUC ACIDS RES SYMP SER, (1980), pages 225 - 232
    - BEUCAGE S.L. ET AL., TETRAHEDRON LETTERS, (1981), vol. 22, pages 1859 - 1869
    - MATTHES ET AL., EMBO J., (1984), vol. 3, pages 801 - 805
    - SAIKI R K ET AL., SCIENCE, (1988), vol. 239, pages 487 - 491
    - DEVEREUX ET AL., NUC. ACIDS RESEARCH, (1984), vol. 12, page 387
    - ALTSCHUL ET AL., J. MOL. BIOL., (1990), pages 403 - 410
    - AUSUBEL ET AL., SHORT PROTOCOLS IN MOLECULAR BIOLOGY, (1999), pages 7 - 58,7-60
    - FEMS MICROBIOL LETT, (1999), vol. 174, no. 2, pages 247 - 50
    - FEMS MICROBIOL LETT, (1999), vol. 177, no. 1, pages 187 - 8
    - HIGGINS DG; SHARP PM, GENE, (1988), vol. 73, no. 1, pages 237 - 244
    - LIVINGSTONE C.D.; BARTON G.J., "Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation", COMPUT.APPL BIOSCI., (1993), vol. 9, pages 745 - 756
    - TAYLOR W.R., "The classification of amino acid conservation", J THEORBIOL., (1986), vol. 119, pages 205 - 218
    - SIMON RJ ET AL., PNAS, (1992), vol. 89, no. 20, pages 9367 - 9371
    - HORWELL DC, TRENDS BIOTECH.NOL., (1995), vol. 13, no. 4, pages 132 - 134
    - MORINAGA ET AL., BIOTECHNOLOGY, (1984), vol. 2, pages 646 - 649
    - NELSON; LONG, ANALYTICAL BIOCHEMISTRY, (1989), vol. 180, pages 147 - 151
    - SARKAR; SOMMER, "The megaprimer method of site directed mutagenesis", BIOTECHNIQUES, (1990), vol. 8, pages 404 - 407
    - SMITH ET AL., GENE, (1988), vol. 70, pages 351 - 361
    - BRADFORD, ANAL. BIOCHEM., (1976), vol. 72, page 248
    - PENNINGA, D.; VAN DER VEEN, B.A.; KNEGTEL, R.M.; VAN HIJUM, S.A.; ROZEBOOM, H.J.; KALK, K.H.; DIJKSTRA, B.W.; DIJKHUIZEN, L., "The raw starch binding domain of cyclodextrin glycosyltransferase from Bacillus circulans strain 251", J.BIOL.CHEM., (1996), vol. 2, no. 71, pages 32777 - 32784
    - ZHOU,J.H.; BABA,T.; TAKANO,T.; KOBAYASHI,S.; ARAI,Y., "Nucleotide sequence of the maltotetraohydrolase gene from Pseudomonas saccharophila", FEBS LETT., (1989), vol. 255, pages 37 - 41
 US20040887056
 US20070006124
 US19390004855
 US20030485413
 US20030485539
 US20030485616
 US20040866903
 US20040886905
 US20040608919
 US20040886023
 US20040886505
 US20040886527
 US20040886504
 US20040947612
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.